Switch to:
Also traded in: Argentina, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.24
CAH's Cash-to-Debt is ranked lower than
78% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. CAH: 0.24 )
Ranked among companies with meaningful Cash-to-Debt only.
CAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.41 Max: 3.34
Current: 0.24
0
3.34
Equity-to-Asset 0.15
CAH's Equity-to-Asset is ranked lower than
91% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. CAH: 0.15 )
Ranked among companies with meaningful Equity-to-Asset only.
CAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.15  Med: 0.34 Max: 0.5
Current: 0.15
0.15
0.5
Debt-to-Equity 1.50
CAH's Debt-to-Equity is ranked lower than
84% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.56 vs. CAH: 1.50 )
Ranked among companies with meaningful Debt-to-Equity only.
CAH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.46 Max: 1.53
Current: 1.5
0.04
1.53
Debt-to-EBITDA 3.25
CAH's Debt-to-EBITDA is ranked lower than
75% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. CAH: 3.25 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CAH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.22  Med: 1.68 Max: 3.51
Current: 3.25
0.22
3.51
Interest Coverage 5.62
CAH's Interest Coverage is ranked lower than
67% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.71 vs. CAH: 5.62 )
Ranked among companies with meaningful Interest Coverage only.
CAH' s Interest Coverage Range Over the Past 10 Years
Min: 5.71  Med: 14.03 Max: 19.27
Current: 5.62
5.71
19.27
Piotroski F-Score: 4
Altman Z-Score: 4.05
Beneish M-Score: -2.62
WACC vs ROIC
6.89%
-1.08%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 1.25
CAH's Operating Margin % is ranked lower than
69% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. CAH: 1.25 )
Ranked among companies with meaningful Operating Margin % only.
CAH' s Operating Margin % Range Over the Past 10 Years
Min: 1.37  Med: 1.71 Max: 2.14
Current: 1.25
1.37
2.14
Net Margin % -0.03
CAH's Net Margin % is ranked lower than
59% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.61 vs. CAH: -0.03 )
Ranked among companies with meaningful Net Margin % only.
CAH' s Net Margin % Range Over the Past 10 Years
Min: 0.19  Med: 0.99 Max: 1.28
Current: -0.03
0.19
1.28
ROE % -0.57
CAH's ROE % is ranked higher than
90% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.39 vs. CAH: -0.57 )
Ranked among companies with meaningful ROE % only.
CAH' s ROE % Range Over the Past 10 Years
Min: 3.98  Med: 17.46 Max: 22.28
Current: -0.57
3.98
22.28
ROA % -0.09
CAH's ROA % is ranked higher than
59% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.37 vs. CAH: -0.09 )
Ranked among companies with meaningful ROA % only.
CAH' s ROA % Range Over the Past 10 Years
Min: 0.64  Med: 4.39 Max: 4.74
Current: -0.09
0.64
4.74
ROC (Joel Greenblatt) % 54.92
CAH's ROC (Joel Greenblatt) % is ranked higher than
83% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.92 vs. CAH: 54.92 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 21.1  Med: 62.14 Max: 122.97
Current: 54.92
21.1
122.97
3-Year Revenue Growth Rate 12.40
CAH's 3-Year Revenue Growth Rate is ranked higher than
70% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.70 vs. CAH: 12.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CAH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.7  Med: 13.2 Max: 43.9
Current: 12.4
-4.7
43.9
3-Year EBITDA Growth Rate 5.40
CAH's 3-Year EBITDA Growth Rate is ranked higher than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.60 vs. CAH: 5.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -10.3  Med: 10.4 Max: 84.5
Current: 5.4
-10.3
84.5
3-Year EPS without NRI Growth Rate -39.20
CAH's 3-Year EPS without NRI Growth Rate is ranked higher than
50% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. CAH: -39.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CAH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -39.2  Med: 9.4 Max: 64.5
Current: -39.2
-39.2
64.5
GuruFocus has detected 2 Warning Signs with Cardinal Health Inc CAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CAH's 30-Y Financials

Financials (Next Earnings Date: 2019-05-03)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2018

CAH Guru Trades in Q1 2018

Richard Pzena 2,873,639 sh (+47.33%)
Steven Cohen 1,266,327 sh (+300.10%)
Barrow, Hanley, Mewhinney & Strauss 18,582,776 sh (+3.95%)
Larry Robbins 3,016,195 sh (+301.61%)
Ray Dalio 606,782 sh (+27.56%)
David Dreman 590 sh (unchged)
Seth Klarman 5,100,000 sh (unchged)
Joel Greenblatt Sold Out
Jim Simons Sold Out
Vanguard Health Care Fund 6,936,246 sh (-8.40%)
Charles Brandes 1,204,802 sh (-3.84%)
John Rogers 850,845 sh (-1.27%)
John Buckingham 22,377 sh (-0.45%)
Mairs and Power 3,244 sh (-2.99%)
Pioneer Investments 1,787,229 sh (-2.18%)
» More
Q2 2018

CAH Guru Trades in Q2 2018

Joel Greenblatt 574,383 sh (New)
Paul Tudor Jones 18,467 sh (New)
Jim Simons 356,400 sh (New)
Charles Brandes 1,968,288 sh (+63.37%)
John Rogers 930,324 sh (+9.34%)
Richard Pzena 2,932,134 sh (+2.04%)
Pioneer Investments 2,027,302 sh (+13.43%)
Ray Dalio 752,906 sh (+24.08%)
Seth Klarman 5,100,000 sh (unchged)
Steven Cohen Sold Out
Mairs and Power Sold Out
Larry Robbins Sold Out
Vanguard Health Care Fund 6,818,446 sh (-1.70%)
John Buckingham 19,481 sh (-12.94%)
Barrow, Hanley, Mewhinney & Strauss 17,802,493 sh (-4.20%)
» More
Q3 2018

CAH Guru Trades in Q3 2018

Charles Brandes 2,025,742 sh (+2.92%)
Jim Simons 2,535,800 sh (+611.50%)
John Buckingham 24,775 sh (+27.18%)
Vanguard Health Care Fund 6,818,446 sh (unchged)
Paul Tudor Jones Sold Out
Richard Pzena 2,595,962 sh (-11.47%)
Barrow, Hanley, Mewhinney & Strauss 17,787,608 sh (-0.08%)
Ray Dalio 178,549 sh (-76.29%)
John Rogers 927,657 sh (-0.29%)
Pioneer Investments 306,353 sh (-84.89%)
Joel Greenblatt 436,325 sh (-24.04%)
Seth Klarman 4,738,485 sh (-7.09%)
» More
Q4 2018

CAH Guru Trades in Q4 2018

John Hussman 1,100 sh (New)
Caxton Associates 6,203 sh (New)
Paul Tudor Jones 40,190 sh (New)
Richard Pzena 3,066,903 sh (+18.14%)
Ray Dalio 782,043 sh (+338.00%)
Joel Greenblatt 437,571 sh (+0.29%)
Vanguard Health Care Fund 6,818,446 sh (unchged)
Charles Brandes 1,858,636 sh (-8.25%)
Jim Simons 2,156,420 sh (-14.96%)
Seth Klarman 1,467,652 sh (-69.03%)
John Rogers 855,750 sh (-7.75%)
Pioneer Investments 265,442 sh (-13.35%)
Barrow, Hanley, Mewhinney & Strauss 9,081,877 sh (-48.94%)
» More
» Details

Insider Trades

Latest Guru Trades with CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 424210    SIC: 5122
Compare:NYSE:ABC, XKRX:091990, NAS:HSIC, HKSE:01099, SHSE:601607, NYSE:MCK, TSE:7459, SZSE:002589, SHSE:600056, SZSE:200028, LSE:UDG, SHSE:600763, NAS:PDCO, NZSE:EBO, SHSE:600090, NYSE:PBH, LSE:CLIN, SHSE:603368, TSE:7476, NYSE:OMI » details
Traded in other countries:CAH.Argentina, CLH.Germany, CAH.Mexico,
Headquarter Location:USA
Cardinal Health Inc is a healthcare services company. It provides services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices.

Cardinal Health is a major distributor of pharmaceuticals and medical supplies to pharmacies and hospitals. Its operations include procurement, packaging, inventory management, and logistics services. Its largest customer is CVS Health retail pharmacy operations.

Ratios

vs
industry
vs
history
Forward PE Ratio 9.19
CAH's Forward PE Ratio is ranked higher than
69% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.99 vs. CAH: 9.19 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
Price-to-Owner-Earnings 8.90
CAH's Price-to-Owner-Earnings is ranked lower than
54% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.94 vs. CAH: 8.90 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CAH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.22  Med: 14.15 Max: 58.55
Current: 8.9
6.22
58.55
PB Ratio 2.49
CAH's PB Ratio is ranked lower than
66% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.12 vs. CAH: 2.49 )
Ranked among companies with meaningful PB Ratio only.
CAH' s PB Ratio Range Over the Past 10 Years
Min: 0.86  Med: 2.64 Max: 4.76
Current: 2.49
0.86
4.76
PS Ratio 0.11
CAH's PS Ratio is ranked higher than
84% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.91 vs. CAH: 0.11 )
Ranked among companies with meaningful PS Ratio only.
CAH' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.15 Max: 0.32
Current: 0.11
0.08
0.32
Price-to-Free-Cash-Flow 9.15
CAH's Price-to-Free-Cash-Flow is ranked higher than
60% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.20 vs. CAH: 9.15 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CAH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.82  Med: 11.21 Max: 43.13
Current: 9.15
5.82
43.13
Price-to-Operating-Cash-Flow 7.66
CAH's Price-to-Operating-Cash-Flow is ranked higher than
55% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.02 vs. CAH: 7.66 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CAH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.68  Med: 9.61 Max: 24.47
Current: 7.66
4.68
24.47
EV-to-EBIT 12.38
CAH's EV-to-EBIT is ranked lower than
69% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.52 vs. CAH: 12.38 )
Ranked among companies with meaningful EV-to-EBIT only.
CAH' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.8  Med: 11.55 Max: 15.4
Current: 12.38
4.8
15.4
EV-to-EBITDA 7.89
CAH's EV-to-EBITDA is ranked higher than
50% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. CAH: 7.89 )
Ranked among companies with meaningful EV-to-EBITDA only.
CAH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.1  Med: 8.6 Max: 12.5
Current: 7.89
4.1
12.5
EV-to-Revenue 0.15
CAH's EV-to-Revenue is ranked higher than
84% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.93 vs. CAH: 0.15 )
Ranked among companies with meaningful EV-to-Revenue only.
CAH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.2 Max: 0.3
Current: 0.15
0.1
0.3
Shiller PE Ratio 16.06
CAH's Shiller PE Ratio is ranked higher than
62% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 27.63 vs. CAH: 16.06 )
Ranked among companies with meaningful Shiller PE Ratio only.
CAH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.64  Med: 15.67 Max: 29.01
Current: 16.06
6.64
29.01
Current Ratio 1.05
CAH's Current Ratio is ranked lower than
87% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. CAH: 1.05 )
Ranked among companies with meaningful Current Ratio only.
CAH' s Current Ratio Range Over the Past 10 Years
Min: 1.05  Med: 1.47 Max: 2.99
Current: 1.05
1.05
2.99
Quick Ratio 0.51
CAH's Quick Ratio is ranked lower than
93% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.12 vs. CAH: 0.51 )
Ranked among companies with meaningful Quick Ratio only.
CAH' s Quick Ratio Range Over the Past 10 Years
Min: 0.42  Med: 0.66 Max: 1.46
Current: 0.51
0.42
1.46
Days Inventory 33.49
CAH's Days Inventory is ranked higher than
60% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.27 vs. CAH: 33.49 )
Ranked among companies with meaningful Days Inventory only.
CAH' s Days Inventory Range Over the Past 10 Years
Min: 25.37  Med: 31.14 Max: 35.34
Current: 33.49
25.37
35.34
Days Sales Outstanding 20.40
CAH's Days Sales Outstanding is ranked higher than
94% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 60.84 vs. CAH: 20.40 )
Ranked among companies with meaningful Days Sales Outstanding only.
CAH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.16  Med: 21.73 Max: 23.22
Current: 20.4
19.16
23.22
Days Payable 55.77
CAH's Days Payable is ranked lower than
65% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.55 vs. CAH: 55.77 )
Ranked among companies with meaningful Days Payable only.
CAH' s Days Payable Range Over the Past 10 Years
Min: 35.78  Med: 49.14 Max: 55.77
Current: 55.77
35.78
55.77

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 3.73
CAH's Dividend Yield % is ranked higher than
72% of the 68 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.59 vs. CAH: 3.73 )
Ranked among companies with meaningful Dividend Yield % only.
CAH' s Dividend Yield % Range Over the Past 10 Years
Min: 1.18  Med: 2.07 Max: 4.25
Current: 3.73
1.18
4.25
Dividend Payout Ratio 189.13
CAH's Dividend Payout Ratio is ranked higher than
80% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. CAH: 189.13 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CAH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.28  Med: 0.38 Max: 189.13
Current: 189.13
0.28
189.13
3-Year Dividend Growth Rate 9.60
CAH's 3-Year Dividend Growth Rate is ranked higher than
57% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.70 vs. CAH: 9.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CAH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 9.6  Med: 17.3 Max: 49.4
Current: 9.6
9.6
49.4
Forward Dividend Yield % 3.81
CAH's Forward Dividend Yield % is ranked higher than
68% of the 69 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.45 vs. CAH: 3.81 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 6.54
CAH's 5-Year Yield-on-Cost % is ranked higher than
68% of the 71 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.97 vs. CAH: 6.54 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CAH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.07  Med: 3.63 Max: 7.46
Current: 6.54
2.07
7.46
3-Year Average Share Buyback Ratio 2.00
CAH's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.90 vs. CAH: 2.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CAH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -38.9  Med: 0.7 Max: 5.7
Current: 2
-38.9
5.7

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.48
CAH's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
81% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. CAH: 0.48 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CAH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.3  Med: 1.23 Max: 8.9
Current: 0.48
0.3
8.9
Price-to-Median-PS-Value 0.74
CAH's Price-to-Median-PS-Value is ranked lower than
65% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.96 vs. CAH: 0.74 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CAH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.55  Med: 1.58 Max: 3.61
Current: 0.74
0.55
3.61
Earnings Yield (Greenblatt) % 8.08
CAH's Earnings Yield (Greenblatt) % is ranked lower than
56% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.16 vs. CAH: 8.08 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CAH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 6.5  Med: 8.65 Max: 20.8
Current: 8.08
6.5
20.8
Forward Rate of Return (Yacktman) % 18.63
CAH's Forward Rate of Return (Yacktman) % is ranked higher than
91% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.37 vs. CAH: 18.63 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CAH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.9  Med: 15.2 Max: 22.2
Current: 18.63
4.9
22.2

More Statistics

Revenue (TTM) (Mil) $141,935.00
EPS (TTM) $ -0.02
Beta1.54
Volatility35.27%
52-Week Range $42.17 - 71.10
Shares Outstanding (Mil)298.02

Analyst Estimate

Jun19 Jun20 Jun21
Revenue (Mil $) 143,961 149,010 155,767
EBIT (Mil $) 2,238 2,348 2,492
EBITDA (Mil $) 2,842 2,978 2,928
EPS ($) 4.52 4.99 5.76
EPS without NRI ($) 4.52 4.99 5.76
EPS Growth Rate
(Future 3Y To 5Y Estimate)
59.29%
Dividends per Share ($) 1.97 2.07 2.09

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAN
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}